Last Tuesday, the Committee heard two bills which would substantially revise cannabis advertising law and recommended passage of the home grow bill.
Five cannabis-related bills were scheduled for consideration in four committee meetings and the WSLCB Board will likely receive its first legislative update of the session.
Four new cannabis-related bills were heard in the Senate on wholesale discounts, retail robberies, retail sales of CBD products, and industry labor standards.
Quality Control and Cannabis Penalties rulemaking projects were advanced and the Board was encouraged to support HB 2279 to establish a framework for craft cannabis in Washington state.
Revised cannabis penalties and QA rules were poised to be advanced at Wednesday’s board meeting and the WSLCB Director expanded on his testimony to the Legislature.
WSLCB Director Rick Garza spoke about restructuring agency enforcement and the Committee heard HB 2296 and HB 2300 regarding cannabidiol (CBD) products.
11 cannabis-related bills were scheduled for consideration in 5 committee meetings while the WSLCB planned action on Cannabis Penalties and Quality Control Testing rules.
Public hearings on cannabis-related bills HB 2263 and HB 2361 filled the hearing room to capacity, and generated significantly more resistance than promotion.
Board members received training from the Executive Ethics Board and discussed the addition of a second patient representative to the Cannabis Advisory Council.
New details on the WSLCB’s legislative agenda, a Regulators Roundtable redux, plus an update on testing labs, the traceability contract, and the Hillard Heintze report.